National Research Corporation $NRC Shares Bought by American Century Companies Inc.

American Century Companies Inc. lifted its stake in National Research Corporation (NASDAQ:NRC) by 7.3% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 42,102 shares of the company’s stock after acquiring an additional 2,848 shares during the period. American Century Companies Inc. owned 0.18% of National Research worth $539,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently added to or reduced their stakes in the company. Tower Research Capital LLC TRC lifted its position in National Research by 376.6% in the fourth quarter. Tower Research Capital LLC TRC now owns 2,507 shares of the company’s stock worth $44,000 after purchasing an additional 1,981 shares during the period. Significant Wealth Partners LLC acquired a new stake in shares of National Research in the first quarter valued at $131,000. Jane Street Group LLC lifted its holdings in shares of National Research by 8.6% in the fourth quarter. Jane Street Group LLC now owns 10,605 shares of the company’s stock valued at $187,000 after buying an additional 840 shares during the period. MetLife Investment Management LLC lifted its holdings in shares of National Research by 28.7% in the fourth quarter. MetLife Investment Management LLC now owns 11,630 shares of the company’s stock valued at $205,000 after buying an additional 2,592 shares during the period. Finally, M&T Bank Corp acquired a new stake in shares of National Research in the first quarter valued at $164,000. 47.26% of the stock is currently owned by institutional investors and hedge funds.

National Research Price Performance

Shares of NASDAQ NRC opened at $15.40 on Friday. National Research Corporation has a twelve month low of $9.76 and a twelve month high of $22.99. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 3.61. The company has a market capitalization of $355.12 million, a price-to-earnings ratio of 20.26 and a beta of 0.47. The firm has a 50-day moving average of $15.05 and a two-hundred day moving average of $14.26.

National Research (NASDAQ:NRC) last issued its quarterly earnings results on Monday, July 28th. The company reported $0.28 earnings per share for the quarter. National Research had a net margin of 12.78% and a return on equity of 83.52%. The company had revenue of $34.04 million during the quarter.

National Research Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 10th. Stockholders of record on Friday, September 26th will be given a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 3.1%. The ex-dividend date is Friday, September 26th. National Research’s dividend payout ratio is 63.16%.

About National Research

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.